Trial intelligence / Profile preview

G-Series Media with Antioxidants vs Standard Media in IVF

NCT02999958Completed

Sponsor
Vitrolife
Start
Dec 2016
Primary completion
May 2018
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Vitrolife. Primary endpoint: Percentage of good quality blastocysts per fertilized oocyte at Day 5. Started Dec 2016; status: completed.

Beyond the preview

Go deeper on NCT02999958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02999958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call